回复@Kertosis: 第二个 H.C. Wainwright analyst Mitchell Kapoor maintains Legend Biotech with a buy rating, and adjusts the target price from $60 to $50.//@Kertosis:回复@情商堪忧的舔狗:TD Cowen昨天知道第四季度销售额后把目标价降到了21美元第一个接受现实的投行。